Accession Number: | 0001104659-22-123224 |
Date: | 2022-11-29 |
Issuer: | AVADEL PHARMACEUTICALS PLC (AVDL) |
Original Submission Date: |
MCHUGH THOMAS S
C/O AVADEL PHARMACEUTICALS PLC
10 EARLSFORT TERRACE
DUBLIN 2, L2 D02 T380
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
ADSS | 2022-11-29 | P | 5,000 | a | $7.80 | 76,500 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the issuer's "adss" are american depositary shares, with each ads representing one ordinary share, nominal value $0.01 per share, of the issuer; adss may be represented by american depositary receipts. |